GENWAND Trademark

Trademark Overview


On Tuesday, November 2, 2021, a trademark application was filed for GENWAND with the United States Patent and Trademark Office. The USPTO has given the GENWAND trademark a serial number of 79331542. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Nanjing Genscript Biotech Co., Ltd.. The GENWAND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technological research in the field of gene synthesis; scientific research; research and development of new products for others; scientific laboratory services; biochemical research; biochemical research and analysis; biotechnology research; biomedical research services; biological cloning services; pharmaceutical research services; bacteriological research and analysis; structural and functional analysis of genomes; medical and scientific research, namely, conducting clinical trials for others; medical research; medical laboratory services; stem cell research services; research and development of antibodies; genetic testing for scientific research purposes; testing of pharmaceuticals
genwand

General Information


Serial Number79331542
Word MarkGENWAND
Filing DateTuesday, November 2, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6915013
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Pseudo MarkGENETIC WAND
Goods and ServicesTechnological research in the field of gene synthesis; scientific research; research and development of new products for others; scientific laboratory services; biochemical research; biochemical research and analysis; biotechnology research; biomedical research services; biological cloning services; pharmaceutical research services; bacteriological research and analysis; structural and functional analysis of genomes; medical and scientific research, namely, conducting clinical trials for others; medical research; medical laboratory services; stem cell research services; research and development of antibodies; genetic testing for scientific research purposes; testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanjing Genscript Biotech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameNanjing Genscript Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameNanjing Genscript Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, February 20, 2023NOTIFICATION PROCESSED BY IB
Friday, January 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 26, 2023FINAL DISPOSITION PROCESSED
Thursday, January 5, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 31, 2022NOTICE OF PUBLICATION
Friday, August 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 12, 2022ASSIGNED TO EXAMINER
Friday, July 22, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 15, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 31, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB